EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® technology, today announced that the U.S. Patent & Trademark Office has issued a Notice of Allowance for its U.S. patent application entitled, “Antifungal Nail Coat and Method of Use.” The patent, when issued, will cover NM100060, a topical application of terbinafine formulated with NexACT® for the treatment of onychomycosis, and will provide coverage to April 17, 2026.
